文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

基于与临床样本中逆转录聚合酶链反应(RT-PCR)的一致性对微阵列预处理算法进行评估。

Evaluation of microarray preprocessing algorithms based on concordance with RT-PCR in clinical samples.

作者信息

Gyorffy Balazs, Molnar Bela, Lage Hermann, Szallasi Zoltan, Eklund Aron C

机构信息

Hungarian Academy of Sciences and Semmelweis University Budapest, Budapest, Hungary.

出版信息

PLoS One. 2009 May 21;4(5):e5645. doi: 10.1371/journal.pone.0005645.


DOI:10.1371/journal.pone.0005645
PMID:19461970
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2680989/
Abstract

BACKGROUND: Several preprocessing algorithms for Affymetrix gene expression microarrays have been developed, and their performance on spike-in data sets has been evaluated previously. However, a comprehensive comparison of preprocessing algorithms on samples taken under research conditions has not been performed. METHODOLOGY/PRINCIPAL FINDINGS: We used TaqMan RT-PCR arrays as a reference to evaluate the accuracy of expression values from Affymetrix microarrays in two experimental data sets: one comprising 84 genes in 36 colon biopsies, and the other comprising 75 genes in 29 cancer cell lines. We evaluated consistency using the Pearson correlation between measurements obtained on the two platforms. Also, we introduce the log-ratio discrepancy as a more relevant measure of discordance between gene expression platforms. Of nine preprocessing algorithms tested, PLIER+16 produced expression values that were most consistent with RT-PCR measurements, although the difference in performance between most of the algorithms was not statistically significant. CONCLUSIONS/SIGNIFICANCE: Our results support the choice of PLIER+16 for the preprocessing of clinical Affymetrix microarray data. However, other algorithms performed similarly and are probably also good choices.

摘要

背景:已经开发了几种用于Affymetrix基因表达微阵列的预处理算法,并且之前已经评估了它们在掺入数据集中的性能。然而,尚未对在研究条件下采集的样本上的预处理算法进行全面比较。 方法/主要发现:我们使用TaqMan RT-PCR阵列作为参考,以评估Affymetrix微阵列在两个实验数据集中表达值的准确性:一个数据集包含36份结肠活检样本中的84个基因,另一个数据集包含29个癌细胞系中的75个基因。我们使用两个平台上获得的测量值之间的Pearson相关性来评估一致性。此外,我们引入对数比率差异作为基因表达平台之间不一致性的更相关度量。在所测试的九种预处理算法中,PLIER + 16产生的表达值与RT-PCR测量结果最一致,尽管大多数算法之间的性能差异没有统计学意义。 结论/意义:我们的结果支持选择PLIER + 16对临床Affymetrix微阵列数据进行预处理。然而,其他算法表现相似,可能也是不错的选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3570/2680989/9e914c64a6f0/pone.0005645.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3570/2680989/0b44d795aed1/pone.0005645.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3570/2680989/58e6d50b2da0/pone.0005645.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3570/2680989/9e914c64a6f0/pone.0005645.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3570/2680989/0b44d795aed1/pone.0005645.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3570/2680989/58e6d50b2da0/pone.0005645.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3570/2680989/9e914c64a6f0/pone.0005645.g003.jpg

相似文献

[1]
Evaluation of microarray preprocessing algorithms based on concordance with RT-PCR in clinical samples.

PLoS One. 2009-5-21

[2]
Probe set filtering increases correlation between Affymetrix GeneChip and qRT-PCR expression measurements.

BMC Bioinformatics. 2010-2-24

[3]
Comparing the use of Affymetrix to spotted oligonucleotide microarrays using two retinal pigment epithelium cell lines.

Mol Vis. 2003-10-6

[4]
Cross-platform comparison of SYBR Green real-time PCR with TaqMan PCR, microarrays and other gene expression measurement technologies evaluated in the MicroArray Quality Control (MAQC) study.

BMC Genomics. 2008-7-11

[5]
Validation of oligonucleotide microarray data using microfluidic low-density arrays: a new statistical method to normalize real-time RT-PCR data.

Biotechniques. 2005-5

[6]
Micro-Analyzer: automatic preprocessing of Affymetrix microarray data.

Comput Methods Programs Biomed. 2013-5-31

[7]
Redefinition of Affymetrix probe sets by sequence overlap with cDNA microarray probes reduces cross-platform inconsistencies in cancer-associated gene expression measurements.

BMC Bioinformatics. 2005-4-25

[8]
Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarrays.

BMC Genomics. 2006-3-21

[9]
Differential gene expression patterns revealed by oligonucleotide versus long cDNA arrays.

Toxicol Sci. 2002-10

[10]
Three microarray platforms: an analysis of their concordance in profiling gene expression.

BMC Genomics. 2005-5-5

引用本文的文献

[1]
PCSK9 expression and cancer survival: a prognostic biomarker at the intersection of oncology and geroscience.

Geroscience. 2025-6-27

[2]
NRF2 pathway activation predicts poor prognosis in lung cancer: a cautionary note on antioxidant interventions.

Geroscience. 2025-6-19

[3]
Prognostic impact of a senescence gene signature in multiple myeloma.

Geroscience. 2025-3-25

[4]
Senescence-related genes as prognostic indicators in breast cancer survival.

Geroscience. 2024-10-21

[5]
Immune Cells and Transcriptional Signatures Revealed Novel Regulators and Predict Clinical Response to Biologic Therapy in Ulcerative Colitis.

J Cell Immunol. 2021

[6]
Identification of four novel hub genes as monitoring biomarkers for colorectal cancer.

Hereditas. 2022-1-29

[7]
Long Noncoding RNA Regulates Cell Proliferation and Migration in Human Esophageal Squamous Cell Carcinoma.

J Cancer. 2022-1-1

[8]
Primary Founder Mutations in the Gene Increase Tumor Mutation Load in Colorectal Cancer.

Int J Mol Sci. 2022-1-6

[9]
A Gene-Based Machine Learning Classifier Associated to the Colorectal Adenoma-Carcinoma Sequence.

Biomedicines. 2021-12-17

[10]
Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer.

Comput Struct Biotechnol J. 2021-7-18

本文引用的文献

[1]
Inflammation, adenoma and cancer: objective classification of colon biopsy specimens with gene expression signature.

Dis Markers. 2008

[2]
Comprehensive analysis of affymetrix exon arrays using BioConductor.

PLoS Comput Biol. 2008-2

[3]
Correction of technical bias in clinical microarray data improves concordance with known biological information.

Genome Biol. 2008

[4]
The utility of MAS5 expression summary and detection call algorithms.

BMC Bioinformatics. 2007-7-30

[5]
Comparative analysis of microarray normalization procedures: effects on reverse engineering gene networks.

Bioinformatics. 2007-7-1

[6]
A distribution free summarization method for Affymetrix GeneChip arrays.

Bioinformatics. 2007-2-1

[7]
The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements.

Nat Biotechnol. 2006-9

[8]
Evaluation of external RNA controls for the assessment of microarray performance.

Nat Biotechnol. 2006-9

[9]
Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer.

J Clin Oncol. 2006-9-10

[10]
Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis.

J Natl Cancer Inst. 2006-2-15

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索